Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-24 @ 3:17 PM
NCT ID:
NCT01732692
Eligibility Criteria:
Inclusion Criteria:
* male or female ≥18 years and ≤ 85 years
* colonoscopy procedure indicated
* willing to stay in the outpatient clinical site for colonoscopy and questionnaire completion
* willing and able to undergo study-related procedures
* informed consent signed by a patient for participation in the study
* negative pregnancy test in women with childbearing potential and consent for double barrier method birth control for subjects, men and women, during the study
Exclusion Criteria:
* ileus
* suspected colonic tumor with manifestations of intestinal obstruction
* delayed gastric emptying (gastroparesis), weak vomiting reflex, tendency to aspiration and regurgitation
* toxic megacolon which is a result of severe inflammatory conditions of the colon including Crohn's disease and ulcerative colitis
* suspected intestinal perforation or risk of gastrointestinal perforation
* signs of severe intestinal bleeding
* acute inflammatory anal or perianal pathology
* severe concomitant diseases of internal organs
* psychiatric diseases in aggravation stage
* hypersensitivity to polyethylene glycol and/or any component of MOVIPREP® preparation
* phenylketonuria or diagnosed glucose-6-phosphate dehydrogenate deficiency
* unconsciousness
* dehydration
* severe inflammatory diseases
* acute abdominal pain of unknown etiology
* pregnancy and lactation period
* participation in any other clinical study (including studies of experimental devices) in 30 days prior participation in the present trial
* patients who test positive for human immunodeficiency virus (HIV)/autoimmune disease (AID), Wasserman reaction (RW) or hepatitis B virus (HBC)
* any condition or circumstance that, in the opinion of the Investigator, would compromise the safety of the participant or the quality of study data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT01732692
Study Brief:
Protocol Section:
NCT01732692